Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet REFACTO AF 500UI powder and solution for solution for injection
- Product code:
- W61060001
- Quantity:
- 1
- Indicated for:
- bleeding; coagulation disorders
- Route of administration:
- injectable
- Substance:
- moroctocog alfa (anticoagulant)
- ATC
- B02BD02 — Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.
Moroctocog alfa is a medication used for the treatment and prevention of bleeding episodes in patients with hemophilia A. It is a recombinant form of coagulation factor VIII, essential for blood clotting.
The medication is administered intravenously and is indicated for both the treatment of acute bleeding episodes and long-term prophylaxis. It is effective in reducing the frequency of bleeding episodes and preventing associated complications.
Side effects may include headache, fever, injection site reactions, or, in rare cases, severe allergic reactions. It is important to monitor factor VIII levels and follow your doctor's instructions.
Consult your doctor to discuss the benefits and risks of treatment with Moroctocog alfa. Regular monitoring is essential to ensure the therapy's effectiveness.
The medication is administered intravenously and is indicated for both the treatment of acute bleeding episodes and long-term prophylaxis. It is effective in reducing the frequency of bleeding episodes and preventing associated complications.
Side effects may include headache, fever, injection site reactions, or, in rare cases, severe allergic reactions. It is important to monitor factor VIII levels and follow your doctor's instructions.
Consult your doctor to discuss the benefits and risks of treatment with Moroctocog alfa. Regular monitoring is essential to ensure the therapy's effectiveness.
General data about REFACTO AF 500UI
- Substance:
- moroctocog alfa
- Date of latest medicines list:
- 01-06-2024
- Product code:
- W61060001
- Concentration:
- 500UI
- Pharmaceutical form:
- powder and solution for solution for injection
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for moroctocog alfa
Concentrations available for moroctocog alfa
- 1000UI
- 2000UI
- 250UI
- 500UI